Phenaris

Phenaris is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

https://www.phenaris.com/

Latest Tweets

Edelweiss Connect (2 weeks ago)
Prediction of cholestatic potential of drugs and investigation of mechanisms underlying cholestasis #HepaRG #liver… https://t.co/s0Hz1regB5
Edelweiss Connect (4 weeks ago)
New article on HepaRG™ ability to predict drug-cholestatic liability #HepaRG #liver #invitro #DILI… https://t.co/BXaV92exdY
Edelweiss Connect (4 weeks ago)
RT @barryhardy: High throughput prediction of hepatocyte toxicity Signup and abstract for the #SaferWorldbyDesign webinar on this topic w…
Edelweiss Connect (4 weeks ago)
Accurate High-Throughput Prediction of Hepatocyte Toxicity in Humans #SaferWorldbyDesign webinar, Feb 2, 14 CET… https://t.co/z4jxibHRKe
Edelweiss Connect (5 weeks ago)
Tuesday, January 26, 16 CET #SaferWorldbyDesign webinar - Cellenion will present its solutions for single-cell anal… https://t.co/VLjDHCe3VX

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA